Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03454646
Other study ID # CHUBX 2016/27
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date June 1, 2024
Est. completion date September 15, 2027

Study information

Verified date October 2023
Source University Hospital, Bordeaux
Contact Jean-François DARTIGUES, M.D., Ph.D
Phone 05 57 82 01 16
Email jean-francois.dartigues@u-bordeaux.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cholinesterase inhibitors (CI) remain the only drugs with a recognized efficacy in mild to moderate Alzheimer's disease (AD) in spite of enormous research efforts. However, these drugs presented as "symptomatic treatment" of AD are considered as having only a weak effect on the course of AD. The reimbursement of these drugs is regularly challenged due to the lack of evidence for the impact of these drugs on milestones stages of AD evolution (survival without severe dementia, restriction in Basic Activities of Daily Living - BADL) and on major consequences in public health (hospitalization and institutionalization). The great majority of previous randomized controlled trials conducted with CI have had a too short duration and the end points were limited to cognition (ADAS Cog scale), IADL (Instrumental Activities of Daily Living) function and Global Impression of Change. New evidences from the DOMINO trial (1) conducted in UK, independently of the pharmaceutical industry, showed that the true effect of CI might be more to avoid or to delay the cognitive or functional decline in AD than to improve patients; the institutionalisation (2) was also delayed. However, this trial was conducted in patients with moderate to severe AD, and the interest of the drugs at the mild to moderate stage remains questionable. The investigators have shown that a good surrogate marker of survival without severe dementia would be an increase of ADAS Cog scale of more than six points (3). A post hoc reanalysis of the pivotal RCT with two CI showed that in mild to moderate patients, CI was associated with a 15% decrease of patients with a deterioration of ADAS-Cog of more than six points in six months. Thus at the beginning of dementia the real effect of CI might be more of delaying the cognitive and functional decline, than to improve the patients. The main objective of the SOS trial is to demonstrate that the benefit of CI at the early phase of dementia is the same as at the later phase.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1205
Est. completion date September 15, 2027
Est. primary completion date April 27, 2027
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - New case of AD referring to a CMRR or MC. - Diagnosis of probable or possible AD, defined according to the NINCDS-ARDRA criteria - Mild to moderate stage, defined by a MMSE score above 15 at the time of pre-inclusion - Patients with indication to CI treatment - Patients Naïve to CI treatment - Patients aged 50 years or more - Menopause or effective contraception (for women) - Affiliated person or beneficiary of a social security scheme - Patients with AD LTI (Long Term Illeness) - Patients agree to participate, with free, informed and written consent signed by the patient and his caregiver Non Inclusion Criteria: - Patients diagnosed with Lewy bodies disease, fronto-temporal dementia, or dementia from a cause other than Alzheimer Disease - More severe stage of the disease, defined by a MMSE equal or below 15 at the time of inclusion - Patients with contraindication to CI treatment - Patients residing in an institution at the time of pré-inclusion or randomization - Patients with a complete dependency for bathing and dressing at the time of pré-inclusion or randomization ( ADL de Katz, score 2/2 for the item "bathing" and/or "dressing") - Patients under tutorship or curatorship, patients unable to express consent - Patients with unstable severe general disease compromising the follow-up - Patients without caregiver - Patients included in another pharmacological trial - Pregnant or breastfeeding women Exclusion Criteria: - CI responder patients for whom the MMSE score remained stable or became higher after 6 months of treatment - Patients with complete dependency for bathing and dressing at the randomization visit - Patients residing in an institution at the randomization visit

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine)
The choice of the treatment will be done by the specialist according to his habits; the specialist will monitor the treatment as usual. All the recruited patients will be treated by CI according to the recommendations of the French HAS and the clinician's habits to choose the type of CI and adjust the dosage. After a 6-month period under CI treatment, patients will be classified according to the evolution of the Mini Mental State Examination (MMSE) as "non-responders" or responders. Responders patients will continue their treatment according to the habits of the clinician. Non-responder patients will be included in the RCT, with individual randomization in two groups: one group who stops the CI, one group who continues the CI. All randomized patients will then be followed-up for two years with regular assessment of judgment criteria every 6 months.

Locations

Country Name City State
France CHU d'Amiens Centre Mémoire Ressources Recherche Amiens
France CHU d'Angers Centre Mémoire Ressources Recherche Angers
France CHU de Bastia Centre Mémoire Ressources Recherche Bastia
France CHU de Besançon Centre Mémoire Ressources Recherche Besançon
France CHU de Bordeaux - Service de Neurologie - Centre Mémoire Ressources Recherche - Bordeaux
France CHRU Cavale Blanche Service de Gériatrie Brest
France Service de Neuropsychologie Hôpital Neurologique Pierre Wertheimer Bron
France CHU Côte de Nacre Service de neurologie et CMRR Caen
France CHU de Clermont Ferrand Centre Mémoire Ressources Recherche Clermont-Ferrand
France Hôpital Pasteur Service de Neurologie Colmar
France CHU de Dijon- CMRR Dijon
France Chu de Grenoble CMRR, Neurologie Grenoble
France Hôpital Roger Salengro CMRR Lille
France CHU Limoges Service de neurologie et CMRR Limoges
France AP-HM Marseille
France CHU Montpellier Hôpital Gui de Chauliac CMRR Montpellier
France CHU de Nantes Clinique Neurologique Hôpital GR Laennec Nantes
France Institut Claude Pompidou Centre Mémoire de Ressources et de Recherche Nice
France APHP Groupe Hospitalier Saint Louis Lariboisière Fernand Widal CMRR Paris
France APHP Hôpital Broca Paris
France Hôpital Universitaire de la Pitié Salpêtrière Pavillon François Lhermitte Paris
France CHU La Milétrie Pôle de Gériatrie Poitiers
France CHU Reims Hôpital Maison Blanche Court Séjour Gériatrique Reims
France CHU de Rennes - Hôpital Pontchaillou / Service de Neurologie Rennes
France CHU de Rouen Hôpital Charles Nicolle Service Neurologie Rouen
France Chu de Saint-Etienne, CMRR Saint-Étienne
France Chu de Strasbourg Hôpital Ka Robertsau Pôle de Gériatrie - CMRR Strasbourg
France Centre de Recherche Clinique du Gérontopôle Cité de la Santé Toulouse
France CHRU de Bretonneau Unité de gérontopsychiatrie Tours
France CHU Nancy Service de Gériatrie-CMRR Vandoeuvre les nancy
France Hospice Civil de Lyon Hôpital des Charpennes Villeurbanne

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Bordeaux

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome is a combination of complete BADL dependency in bathing and dressing and/or institutionalization or death at 2 years after randomization. Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at 30 months after patient's inclusion
Secondary BADL dependency will be evaluated by the clinician using the BADL scale from Katz [17]. Each of the components of the combined primary outcome, as defined above, analyzed separately.
As previously demonstrated, bathing and dressing are the first ADL losses, also defined by Katz et al. as the thresholds of disability [17] [18]. A total limitation in bathing and dressing will be considered (each item is coded from 0 - no limitation, to 2 - total limitation).
at inclusion
Secondary BADL dependency will be evaluated by the clinician using the BADL scale from Katz [17]. Each of the components of the combined primary outcome, as defined above, analyzed separately.
As previously demonstrated, bathing and dressing are the first ADL losses, also defined by Katz et al. as the thresholds of disability [17] [18]. A total limitation in bathing and dressing will be considered (each item is coded from 0 - no limitation, to 2 - total limitation).
at 6 months
Secondary BADL dependency will be evaluated by the clinician using the BADL scale from Katz [17]. Each of the components of the combined primary outcome, as defined above, analyzed separately As previously demonstrated, bathing and dressing are the first ADL losses, also defined by Katz et al. as the thresholds of disability [17] [18]. A total limitation in bathing and dressing will be considered (each item is coded from 0 - no limitation, to 2 - total limitation). at 12 months
Secondary BADL dependency will be evaluated by the clinician using the BADL scale from Katz [17]. Each of the components of the combined primary outcome, as defined above, analyzed separately As previously demonstrated, bathing and dressing are the first ADL losses, also defined by Katz et al. as the thresholds of disability [17] [18]. A total limitation in bathing and dressing will be considered (each item is coded from 0 - no limitation, to 2 - total limitation). at 18 months
Secondary BADL dependency will be evaluated by the clinician using the BADL scale from Katz [17]. Each of the components of the combined primary outcome, as defined above, analyzed separately As previously demonstrated, bathing and dressing are the first ADL losses, also defined by Katz et al. as the thresholds of disability [17] [18]. A total limitation in bathing and dressing will be considered (each item is coded from 0 - no limitation, to 2 - total limitation). at 24 months
Secondary BADL dependency will be evaluated by the clinician using the BADL scale from Katz [17]. Each of the components of the combined primary outcome, as defined above, analyzed separately As previously demonstrated, bathing and dressing are the first ADL losses, also defined by Katz et al. as the thresholds of disability [17] [18]. A total limitation in bathing and dressing will be considered (each item is coded from 0 - no limitation, to 2 - total limitation). at 30 months
Secondary Combination of complete BADL dependency in bathing and dressing and/or institutionalization or death Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at inclusion
Secondary Combination of complete BADL dependency in bathing and dressing and/or institutionalization or death Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at 6 months
Secondary Combination of complete BADL dependency in bathing and dressing and/or institutionalization or death Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at 12 months
Secondary Combination of complete BADL dependency in bathing and dressing and/or institutionalization or death Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at 18 months
Secondary Combination of complete BADL dependency in bathing and dressing and/or institutionalization or death Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at 24 months
Secondary Combination of complete BADL dependency in bathing and dressing and/or institutionalization or death Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information.
Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status.
For dependency in bathing and dressing, although it could be considered as less objective, we choose a level of total dependency, easy to assess with very low risk of misinterpretation.
at 30 months
Secondary Institutionalization with date of entry Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information. at inclusion
Secondary Institutionalization with date of entry Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information. at 6 months
Secondary Institutionalization with date of entry Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information. at 12 months
Secondary Institutionalization with date of entry Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information. at 18 months
Secondary Institutionalization with date of entry Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information. at 24 months
Secondary Institutionalization with date of entry Institutionalization with date of entry will be assessed by specialist at each follow-up time every 6 months. For patients not coming to the memory consultation, caregiver (formal and/or informal) and/or the general practitioner will be systematically contacted to obtain the information. at 30 months
Secondary Death and date of death Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status. at inclusion
Secondary Death and date of death Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status. at 6 months
Secondary Death and date of death Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status. at 12 months
Secondary Death and date of death Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status. at 18 months
Secondary Death and date of death Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status. at 24 months
Secondary Death and date of death Death and date of death will be assessed by contacting proxy or general practitioner. In case of lack of information the birth City Hall will be contacted to assess the vital status. at 30 months
Secondary the ADL scale ADL DE KATZ BATHING :+-+/2 0 bathes self completely
needs help in bathing only one part of the body
needs help with bathing more than one part of the body or not bathed DRESSING :+-+ /2
0 gets clothes and gets completely dressed without assistance
1 gets clothes and gets dressed without assistance, except for assistance in tying shoes 2 receives assistance in getting clothes or in getting dressed, or stays partly or completely undressed TOILETING :+-+/2 0 toileting without assistance (may use cane, walker, or wheelchair)
1 receives assistance 2 doesn't go to room termed " toilet ". TRANSFER:+-+/2 0 transfer without assistance (may be using cane or walker)
transfer with assistance
doesn't get out of bed. FEEDING :+-+/2
0 feeding without help
need help cutting meat or buttering bread
needs total help or requires parenteral feeding. TOTAL : +---+/10 If the patient has a result of 2 at bathing and or dressing he can't be included at T0.
at inclusion
Secondary the ADL scale ADL DE KATZ BATHING :+-+/2 0 bathes self completely
needs help in bathing only one part of the body
needs help with bathing more than one part of the body or not bathed DRESSING :+-+ /2
0 gets clothes and gets completely dressed without assistance
1 gets clothes and gets dressed without assistance, except for assistance in tying shoes 2 receives assistance in getting clothes or in getting dressed, or stays partly or completely undressed TOILETING :+-+/2 0 toileting without assistance (may use cane, walker, or wheelchair)
1 receives assistance 2 doesn't go to room termed " toilet ". TRANSFER:+-+/2 0 transfer without assistance (may be using cane or walker)
transfer with assistance
doesn't get out of bed. FEEDING :+-+/2
0 feeding without help
need help cutting meat or buttering bread
needs total help or requires parenteral feeding. TOTAL : +---+/10 If the patient has a result of 2 at bathing and or dressing he can't be randomized at T6M
at 6 months
Secondary the ADL scale ADL DE KATZ BATHING :+-+/2 0 bathes self completely
needs help in bathing only one part of the body
needs help with bathing more than one part of the body or not bathed DRESSING :+-+ /2
0 gets clothes and gets completely dressed without assistance
1 gets clothes and gets dressed without assistance, except for assistance in tying shoes 2 receives assistance in getting clothes or in getting dressed, or stays partly or completely undressed TOILETING :+-+/2 0 toileting without assistance (may use cane, walker, or wheelchair)
1 receives assistance 2 doesn't go to room termed " toilet ". TRANSFER:+-+/2 0 transfer without assistance (may be using cane or walker)
transfer with assistance
doesn't get out of bed. FEEDING :+-+/2
0 feeding without help
need help cutting meat or buttering bread
needs total help or requires parenteral feeding. TOTAL : +---+/10
at 12 months
Secondary the ADL scale ADL DE KATZ BATHING :+-+/2 0 bathes self completely
needs help in bathing only one part of the body
needs help with bathing more than one part of the body or not bathed DRESSING :+-+ /2
0 gets clothes and gets completely dressed without assistance
1 gets clothes and gets dressed without assistance, except for assistance in tying shoes 2 receives assistance in getting clothes or in getting dressed, or stays partly or completely undressed TOILETING :+-+/2 0 toileting without assistance (may use cane, walker, or wheelchair)
1 receives assistance 2 doesn't go to room termed " toilet ". TRANSFER:+-+/2 0 transfer without assistance (may be using cane or walker)
transfer with assistance
doesn't get out of bed. FEEDING :+-+/2
0 feeding without help
need help cutting meat or buttering bread
needs total help or requires parenteral feeding. TOTAL : +---+/10
at 18 months
Secondary the ADL scale ADL DE KATZ BATHING :+-+/2 0 bathes self completely
needs help in bathing only one part of the body
needs help with bathing more than one part of the body or not bathed DRESSING :+-+ /2
0 gets clothes and gets completely dressed without assistance
1 gets clothes and gets dressed without assistance, except for assistance in tying shoes 2 receives assistance in getting clothes or in getting dressed, or stays partly or completely undressed TOILETING :+-+/2 0 toileting without assistance (may use cane, walker, or wheelchair)
1 receives assistance 2 doesn't go to room termed " toilet ". TRANSFER:+-+/2 0 transfer without assistance (may be using cane or walker)
transfer with assistance
doesn't get out of bed. FEEDING :+-+/2
0 feeding without help
need help cutting meat or buttering bread
needs total help or requires parenteral feeding. TOTAL : +---+/10
at 24 months
Secondary the ADL scale ADL DE KATZ BATHING :+-+/2 0 bathes self completely
needs help in bathing only one part of the body
needs help with bathing more than one part of the body or not bathed DRESSING :+-+ /2
0 gets clothes and gets completely dressed without assistance
1 gets clothes and gets dressed without assistance, except for assistance in tying shoes 2 receives assistance in getting clothes or in getting dressed, or stays partly or completely undressed TOILETING :+-+/2 0 toileting without assistance (may use cane, walker, or wheelchair)
1 receives assistance 2 doesn't go to room termed " toilet ". TRANSFER:+-+/2 0 transfer without assistance (may be using cane or walker)
transfer with assistance
doesn't get out of bed. FEEDING :+-+/2
0 feeding without help
need help cutting meat or buttering bread
needs total help or requires parenteral feeding. TOTAL : +---+/10
at 30 months
Secondary the MMSE score The MMSE score will be assessed by the clinician, the psychologist or the speech therapist according to the habits of the center, using the French version of the MMSE (GRECO version) at inclusion
Secondary the MMSE score The MMSE score will be assessed by the clinician, the psychologist or the speech therapist according to the habits of the center, using the French version of the MMSE (GRECO version) at 6 months
Secondary the MMSE score The MMSE score will be assessed by the clinician, the psychologist or the speech therapist according to the habits of the center, using the French version of the MMSE (GRECO version) at 12 months
Secondary the MMSE score The MMSE score will be assessed by the clinician, the psychologist or the speech therapist according to the habits of the center, using the French version of the MMSE (GRECO version) at 18 months
Secondary the MMSE score The MMSE score will be assessed by the clinician, the psychologist or the speech therapist according to the habits of the center, using the French version of the MMSE (GRECO version) at 24 months
Secondary the MMSE score The MMSE score will be assessed by the clinician, the psychologist or the speech therapist according to the habits of the center, using the French version of the MMSE (GRECO version) at 30 months
Secondary the number of hospitalizations The number of hospitalizations will be assessed using standardized questionnaire, with date (month/year) and duration of hospitalization; at inclusion
Secondary the number of hospitalizations The number of hospitalizations will be assessed using standardized questionnaire, with date (month/year) and duration of hospitalization; at 6 months
Secondary the number of hospitalizations The number of hospitalizations will be assessed using standardized questionnaire, with date (month/year) and duration of hospitalization; at 12 months
Secondary the number of hospitalizations The number of hospitalizations will be assessed using standardized questionnaire, with date (month/year) and duration of hospitalization; at 18 months
Secondary the number of hospitalizations The number of hospitalizations will be assessed using standardized questionnaire, with date (month/year) and duration of hospitalization; at 24 months
Secondary the number of hospitalizations The number of hospitalizations will be assessed using standardized questionnaire, with date (month/year) and duration of hospitalization; at 30 months
Secondary Pharmacologie treatments consumed by the patient All the pharmacologie treatments consumed by the patient will be assessed, allowing to assess psychotropic drug consumption. at inclusion
Secondary Pharmacologie treatments consumed by the patient All the pharmacologie treatments consumed by the patient will be assessed, allowing to assess psychotropic drug consumption. at 6 months
Secondary Pharmacologie treatments consumed by the patient All the pharmacologie treatments consumed by the patient will be assessed, allowing to assess psychotropic drug consumption. at 12 months
Secondary Pharmacologie treatments consumed by the patient All the pharmacologie treatments consumed by the patient will be assessed, allowing to assess psychotropic drug consumption. at 18 months
Secondary Pharmacologie treatments consumed by the patient All the pharmacologie treatments consumed by the patient will be assessed, allowing to assess psychotropic drug consumption. at 24 months
Secondary Pharmacologie treatments consumed by the patient All the pharmacologie treatments consumed by the patient will be assessed, allowing to assess psychotropic drug consumption. at 30 months
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A